Healios Successfully Establishes Proprietary Universal Donor C...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TOKYO, June 5, 2020 /Kyodo JBN-AsiaNet/ -- Healios K.K. (hereinafter "the Company"; TSE: 4593), Japan's leading clinical-stage biotechnology company, has been creating Universal Donor Cells (UDCs), which are next-generation iPS cells created with gene-editing technology to engineer a low r...
Authors: LATEST ASIANET NEWS RELEASES